One Step Closer – First Topical Candidate in Phase III Development for Diabetic Macular Edema
Time: 1:30 pm
day: Conference Day Two
Details:
- Enabling the formulation of drugs as topical eye drop treatment with improved solubility, higher concentration, longer residence time, and enhanced bioavailability in eye tissues, including the retina
- Sharing phase III clinical trials data to leverage learnings for the development of non-invasive ophthalmic drug delivery
- Achieving reduced ocular inflammation
